3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
3
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
4
Breast Neoplasms
4
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Lymphatic Metastasis
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Giant Cell Tumor of Bone
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Solid Tumor
1
Sarcoma, Ewing
1
Right Hemicolectomy
1
Rhabdomyosarcoma
1
Osteosarcoma
1
Neuroblastoma
1
Mesothelioma, Malignant
1
Melanoma
1
Margins of Excision
1
Lymphoma
1
Inflammatory Breast Neoplasms
1
Giant Cell Tumor of Tendon Sheath
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Breast Cancer Lymphedema
1
Interventions
pembrolizumab
16
Radiotherapy
15
Drug Therapy
14
Paclitaxel
13
Cisplatin
12
Carboplatin
10
Immunotherapy
9
Esophagectomy
9
Radiation
8
Fluorouracil
8
Surgical Procedures, Operative
7
Capecitabine
7
Blood Specimen Collection
7
Oxaliplatin
6
Nivolumab
6
Immune Checkpoint Inhibitors
6
Chemoradiotherapy
6
nimotuzumab
5
Trastuzumab
5
130-nm albumin-bound paclitaxel
5
sintilimab
4
camrelizumab
4
Leucovorin
4
trastuzumab deruxtecan
3
tislelizumab
3
patritumab deruxtecan
3
Surveys and Questionnaires
3
Endoscopy
3
Bevacizumab
3
toripalimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Esophageal Neoplasms
×
Indocyanine Green
×
Clear all
NCT07108855
2025-08-07
BRIGHT
University Medical Center Groningen
Phase 1/2
Recruiting
10 enrolled